Certain types of papillomavirus might actually prevent cervical cancer, according to a new study. More than 100 different types of HPV are known, and approximately 14 "high-risk" HPV types are known to cause cervical cancer.
Abnormal Pap results usually should be followed up with a DNA-based test rather than with another cervical smear, a study indicates.
Revisions to cervical cancer protocols may hinder clinicians diagnosing younger women with AIS
Bevacizumab plus chemotherapy improved survival in women with advanced, recurrent, or persistent cervical cancer, according to interim findings.
A therapeutic vaccine for women who are already harboring human papillomavirus (HPV) appeared to fight cervical cancer in a small, phase 1 study.
Cytology testing recommended every three to five years; co-testing for HPV starting at age 30 years.
Human papillomavirus (HPV) positivity alone is a poor biomarker for HPV-driven head and neck cancers, according to two recent studies.
Young women who have the BRCA1 and BRCA2 gene mutation feel differently about their options for relationships, treatment, childbearing, and careers. In this study, researchers evaluated the psychosocial consequences of carrying the BRCA1 and BRCA2 mutations.
ATA guidelines for well-differentiated thyroid cancer recommend therapeutic neck dissection when the disease is clinically involved or metastatic and prophylactic central neck dissection when tumors are advanced. Nonetheless, though these established guidelines are in place, the surgical management of cervical nodes varies greatly.
HIV-positive women with normal Pap results and no oncogenic HPV do not appear to be at greater risk of cervical CA than HIV-negative women.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|